Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.93 -0.59 (-5.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Corvus Pharmaceuticals' Shares Outstanding (Diluted) came in at 92.37 million for Q2 2026, up 18.8% from 77.77 million a year earlier and up 2.6% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Corvus Pharmaceuticals' Shares Outstanding (Diluted) was 79.74 million, up 30.8% from FY2024.

  • Shares Outstanding (Diluted) has increased in each of the last six years, with a five-year compound annual growth rate of 22.0% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Diluted) was 60.99 million in FY2024 (+27.0%), 48.03 million in FY2023 (+3.2%), 46.55 million in FY2022 (+11.2%) and 41.85 million in FY2021 (+42.0%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2019.
  • Year-over-year, Shares Outstanding (Diluted) has increased for 13 consecutive quarters, with growth averaging 30.0% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.0% (Q1 2023) to 53.3% (Q1 2025).
  • Business Quant data shows CRVS's Shares Outstanding (Diluted) at 90 million (Q1 2026), 79.74 million (Q4 2025) and 82.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Corvus Pharmaceuticals 969.07 Mn 457.51 Mn - 92.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92.37 Mn
Mar 31, 2026 90.00 Mn
Dec 31, 2025 79.74 Mn
Sep 30, 2025 82.84 Mn
Jun 30, 2025 77.77 Mn
Mar 31, 2025 75.15 Mn
Dec 31, 2024 60.99 Mn
Sep 30, 2024 66.70 Mn
Jun 30, 2024 59.71 Mn
Mar 31, 2024 49.04 Mn
Dec 31, 2023 48.03 Mn
Sep 30, 2023 48.97 Mn
Jun 30, 2023 47.50 Mn
Mar 31, 2023 46.56 Mn
Dec 31, 2022 46.55 Mn
Sep 30, 2022 46.55 Mn
Jun 30, 2022 46.55 Mn
Mar 31, 2022 46.55 Mn
Dec 31, 2021 41.85 Mn
Sep 30, 2021 43.95 Mn
API Access

Corvus Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CRVS&period=max&api_key=YOUR_API_KEY